Stockwinners Market Radar for July 16, 2020 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:51 EDT Netflix sees being cash-flow negative again in 2021

18:46 EDT Netflix CEO Hasting feels 'excellent' about 'big bets' in content - Says feels "excellent" about number of "big bets" in content. Says shooting projects in Los Angeles this week. Says "excited" about taking risks.

18:41 EDT Netflix says new subscribers 'highly engaged' and broad-based - Says pricing strategy to vary by country. Says newer members look like pre-existing members, AKA very broad-based. Says new subscribers "highly engaged." Says people who drop service often come back after a while.

18:28 EDT Netflix says Q3 guidance reflects biggest Q2 ever - Says will do less awards marketing than in the past. Says marketing budget down due to COVID-19 pandemic. Says Q3 guidance reflects biggest Q2 ever.

18:19 EDT Netflix says new safety protocols for production to likely become permanent - Says has a good model, just need to "make it better." Says COVID-19 restrictions don't affect too much. Says strategy hasn't fundamentally changed due to COVID-19. Says safety protocols around the world will likely become permanent part of production.

18:02 EDT Ocwen spikes 21% after business update moving forward with reverse split - Shares are up 13c or 20.46% to 78c per share in after-hours trading.

17:03 EDT Duos Technologies Group CEO Gianni Arcaini retiring September 1 - Duos Technologies Founder, CEO and President Gianni Arcaini is retiring September 1. Arcaini will continue to serve as Chairman of the Board. The board has initiated a search for a new President and CEO.

17:02 EDT Turquoise Hill raises FY20 gold production view to 155K-180K oz from 120K-150K

16:32 EDT Oracle to partner with NIH on cloud system to support COVID-19 vaccine trials - The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently established the COVID-19 Prevention Network. Its goal is to register millions of volunteers for large-scale clinical testing of vaccines and monoclonal antibodies intended to protect people from COVID-19. As part of this initiative, Oracle developed a Cloud System called the CoVPN Volunteer Screening Registry to identify and screen volunteers who want to participate in COVID-19 clinical trials. Even though the system has been live for less than a week, more than 100,000 people have already registered. This program is expected to support hundreds of clinical trial sites across the United States and internationally by the end of the year.

16:21 EDT PPG sees Q3 aggregate sales volumes down 8%-15% - Sees restructuring savings $60M-$70M in second half of 2020. Sees Q3 corporate expenses $50M-$55M.

16:17 EDT PPG says 'quick and decisive' actions helped mitigate impact from lower demand - "Our quick and decisive actions at the outset of the pandemic helped to mitigate the earnings impact from the lower demand. Our aggregate segment margins were about 13%, which is a significant improvement versus the depths of the prior recession in 2008/2009 when we experienced similar volume declines, and is measurable proof of the structural cost savings that we have delivered over the past several years. In the quarter, we delivered about $170 million of cost savings from various interim initiatives and more than $20 million of incremental structural savings from business restructuring programs. In June, we initiated a new restructuring program targeting up to $170 million of annualized structural cost savings. In addition, aided by strong working capital management, during the quarter we generated nearly $500 million of cash from operations, similar to second quarter 2019 levels. We also continued our legacy of rewarding shareholders with a 6% quarterly dividend increase, reflecting the resiliency of our business model and capability to generate strong and consistent cash flow. As the pandemic continues, our focus remains on the protection of our employees and providing excellent support to our customers with the essential products and services they need to resume and ramp-up their operations," McGarry added. "Looking ahead, we expect overall economic activity to continue to recover, although at a varied pace across end-use markets and regions given the uncertainty around the ongoing effects of the pandemic. We anticipate positive overall global architectural coatings demand trends to continue, with some moderation from the elevated DIY demand experienced in the second quarter. We expect continued, solid recovery patterns in automotive OEM and general industrial coatings demand in the U.S. and Europe, but still below 2019 levels. Automotive refinish and aerospace coatings sales are expected to be lower until travel and vehicle traffic density return toward more normal levels. Discretionary cost management will continue, particularly in those businesses with longer recovery timelines. We have continued to improve our overall liquidity and will prudently manage cash and our balance sheet. Finally, I am very proud and pleased with how our global team is managing through this challenging time, and we are on the path to emerge from this crisis as an even stronger company," McGarry concluded.

16:16 EDT ADDvantage appoints Jarrod Watson as new CFO - ADDvantage Technologies announced the appointment of Jarrod M. Watson as Chief Financial Officer. Watson joins the company with more than 20 years of corporate financial leadership experience with large organizations including Fortune 500 companies Yum Brands (YUM) and McKesson (MCK). "Jarrod's financial experience and proven track record of success will be invaluable as we execute our plans to improve operations and position for profitable long-term growth," commented Joe Hart, Chief Executive Officer. "He has a proven ability to lead large teams and apply analytics to support strategic decision-making for a number of well-run, multi-billion-dollar organizations. His drive for continual improvement and deep functional expertise in all areas of corporate finance have successfully guided organizations to strong financial health and created incremental value for shareholders and owners. I am confident that Jarrod will be a tremendous asset to our leadership team."

16:13 EDT PetIQ gets FTC approval for closing of 'highly accretive' Capstar acquisition - PetIQ (PETQ) announced they have received final approval from the U.S. Federal Trade Commission and will close the $95M cash acquisition of the Capstar portfolio of products from Elanco Animal Health (ELAN) on July 31. Capstar is the #1 oral over-the-counter flea treatment product in the United States. PetIQ expects that this acquisition will be immediately accretive to earnings following the closing and thereafter due to the strong performance of the brand. The Capstar portfolio is comprised of seven SKUs, including three private label SKUs which are sold under the Capaction brand. Capstar is an oral tablet for the treatment of flea infestations on dogs, puppies, cats and kittens and is currently the best-selling oral OTC flea treatment product in the United States. Additionally, Capstar is the only oral OTC product for cats in the market today. Cord Christensen, PetIQ's Chairman and Chief Executive Officer, commented, "We are excited to have cleared all hurdles needed to close this highly accretive acquisition. We believe the acquisition of Capstar is a natural fit with our pet health and wellness platform as we further enhance PetIQ's manufactured product business with the addition of Capstar's industry leading animal health product portfolio. We have been distributing the Capstar brand for several years and have a deep appreciation for the trust that pet parents have in their flea treatments, which is demonstrated by their very attractive position. We believe that PetIQ is well positioned to support and grow Capstar across sales channels long-term."

16:10 EDT Netflix now sees FY20 free cash flow to be breakeven to positive - Netflix said: "Our FCF profile is continuing to improve, which is being driven in part by our growing operating margin and the digestion of our big move into the production of Netflix originals that requires more cash upfront vs. licensed content. In addition, the pause in production has also pushed out cash spending on content into the second half of 2020 and into 2021. Due to the pause in production from the pandemic combined with higher-than-forecast paid net adds year to date, we now expect free cash flow for the full year 2020 to be breakeven to positive, compared with our prior expectation for -$1 billion or better. As we indicated last quarter, in 2021 we project that full year free cash flow will dip back to being negative again, although we believe the FCF deficit will be materially better than our peak deficit level of -$3.3 billion in 2019. There has been no material change in our overall estimated timetable to reach consistent annual positive FCF within the next few years."

16:09 EDT J.B. Hunt reports Q2 operating income down 9% at $175.2M - Q2 Intermodal Segment revenue was down 7% at $1.07B and operating income down 14% at $107M.

16:09 EDT Netflix slips 11.3% after reporting Q2 results

16:07 EDT Marten Transport announces three-for-two stock split - Chairman and Chief Executive Officer Randolph L. Marten said, ""I am also pleased to announce this stock split which reflects our continued strong financial condition. The increased number of outstanding shares should increase trading activity, or float, in our common stock while our stockholders benefit from the 50% increase in our quarterly dividend cash payout." The three-for-two stock split of the company's common stock will be effected in the form of a stock dividend payable on August 13, 2020 to stockholders of record as of July 30, 2020. Holders of the company's common stock will receive an additional one-half share for each outstanding share of common stock held as of the record date. The stock split will increase the number of outstanding shares of common stock from approximately 55.1 million to approximately 82.7 million shares. The regular quarterly cash dividend of $0.04 per share of common stock will be payable on September 30, 2020 to stockholders of record at the close of business on September 16, 2020. This is Marten's 41st consecutive quarterly cash dividend. With the payment of this dividend, Marten will have paid a total of $93.6 million in cash dividends, including special dividends totaling $52.1 million in 2019 and 2012, since the dividend program was implemented in 2010.

16:06 EDT RumbleOn announces dealer-centric pilot program with CarGurus - RumbleOn (RMBL) announced it was chosen for a pilot program with CarGurus (CARG). CarGurus will leverage RumbleOn's technology as well as their transportation and distribution services in the testing of a new inventory acquisition product for dealers that enables dealers to source consumer cars on the CarGurus platform. RumbleOn CEO Marshall Chesrown commented, "Our proprietary technology suite has underpinned our offering since day one. We have strong relationships with dealers and our agnostic business model has propelled our rapid expansion in both Powersports and Automotive. We are proud that CarGurus has selected RumbleOn for this pilot, and we are excited to help support their new and innovative solutions for dealers around the world."

16:05 EDT Netflix says 'slowly resuming productions in many parts of the world' - Netflix said: "Today, we're slowly resuming productions in many parts of the world. We are furthest along in Asia Pacific (where we never fully shut down in Korea, for example) and are now shooting live action series like season 2 of our Japanese original The Naked Director...Since our content production lead time is long, our 2020 plans for launching original shows and films continue to be largely intact. For 2021, based on our current plan, we expect the paused productions will lead to a more second half weighted content slate in terms of our big titles, although we anticipate the total number of originals for the full year will still be higher than 2020."

16:04 EDT Netflix still targets 16% operating margin for FY20 - Netflix said: "For the full year 2020, we're still targeting a 16% operating margin. We're currently on track to exceed 16% although F/X (and the relative strength of the US dollar) remains a wildcard. As always, our intention is to grow our annual operating margin year over year - we're currently targeting 19% for 2021."

16:03 EDT Netflix appoints Ted Sarandos as co-CEO - "Ted has been my partner for decades. This change makes formal what was already informal -- that Ted and I share the leadership of Netflix," said Reed Hastings. Lead Independent director Jay Hoag said: "Having watched Reed and Ted work together for so long, the board and I are confident this is the right step to evolve Netflix's management structure so that we can continue to best serve our members and shareholders for years to come."

16:02 EDT Netflix reports Q2 global streaming paid net additions of 10.09M - Netflix said in its quarterly letter to investors: "We added a Q2-record 10.1m paid memberships vs. 2.7m in last year's Q2. The positive variance relative to our 7.5m forecast was due to better-than-forecast acquisition and retention. In the first half of this year, we've added 26m paid memberships, nearly on par with the 28m we achieved in all of 2019. However, as we expected, growth is slowing as consumers get through the initial shock of Covid and social restrictions. Our paid net additions for the month of June also included the subscriptions we cancelled for the small percentage of members who had not used the service recently."

16:00 EDT CDC extends 'No Sail Order' for cruise ships - On July 16, the CDC extended the "No Sail Order and Suspension of Further Embarkation; Notice of Modification and Extension and Other Measures Related to Operations" signed by the CDC Director on April 9, subject to the modifications and additional stipulated conditions as set forth in this Order. The Order is effective upon signature and will be published in the Federal Register. This Order is in effect until one of the following occurs: the expiration of the Secretary of Health and Human Services' declaration that COVID-19 constitutes a public health emergency or the CDC Director rescinds or modifies the order based on specific public health or other considerations, or September 30, 2020. Reference Link

15:31 EDT Twitter says 'no evidence' attackers accessed passwords - Twitter said in a series of tweets via its Twitter Support account: "We have no evidence that attackers accessed passwords. Currently, we don't believe resetting your password is necessary. Out of an abundance of caution, and as part of our incident response yesterday to protect people's security, we took the step to lock any accounts that had attempted to change the account's password during the past 30 days. As part of the additional security measures we've taken, you may not have been able to reset your password. Other than the accounts that are still locked, people should be able to reset their password now. If your account was locked, this does not necessarily mean we have evidence that the account was compromised or accessed. So far, we believe only a small subset of these locked accounts were compromised, but are still investigating and will inform those who were affected. We're working to help people regain access to their accounts ASAP if they were proactively locked. This may take additional time since we're taking extra steps to confirm that we're granting access to the rightful owner. We've been working around the clock and will continue to provide updates here." Reference Link

15:03 EDT EU launches sector inquiry into markets for products, services linked to IoT - The European Commission has launched a sector inquiry into the markets for consumer products and services linked to the Internet of Things. "In Europe, the total number of smart home devices was around 108 million at the end of 2019 and is forecast to reach 184 million devices by 2023. And the value of the smart home market is expected to almost double in the next four years to more than 27 billion Euros," said commissioner Margrethe Vestager. "That includes smart home appliances - like TVs, fridges or lights - that are connected to the Internet. So we can control them from a distance, and they can talk to each other, and even learn to anticipate our needs. It includes wearables, like smartwatches and fitness trackers. They monitor our exercise and our wellbeing, and could even help us spot health problems early. And at the centre of it all, there are voice assistants, like Apple's (AAPL) Siri, Google Assistant (GOOG), Amazon's Alexa (AMZN) or Deutsche Telekom's (DTEGY) Magenta. Those voice assistants allow us to control our smart devices without us having to look at a screen. You can get information from the Internet, manage calendars or buy products. The potential is incredible. But we'll only see the full benefits - low prices, wide choice, innovative products and services - if the markets for these devices stay open and competitive. And the trouble is that competition in digital markets can be fragile. When big companies abuse their power, they can very quickly push markets beyond the tipping point, where competition turns to monopoly. We've seen that happen before. If we don't act in good time, there's a serious risk that it will happen again, with the Internet of Things." Reference Link

14:10 EDT Walgreens to require face covers at all U.S. stores - Walgreens announced is expanding requirements for customers to wear face covers while in stores across all Walgreens locations chainwide, citing "growing numbers of health officials, including the Centers for Disease Control and Prevention, are now urging everyone across the U.S. to wear face covers in public to help protect communities and stem the spread of COVID-19." There will be new and additional signage on exterior doors with this information, stores will also be increasing the frequency of reminders to customers via the stores' intercom system, the company said. The change will take effect Monday, July 20.

13:56 EDT Carnival sells four ships in Holland America Line, will cancel cruises - Carnival's Holland America Line announced that Amsterdam, Maasdam, Rotterdam and Veendam will be leaving the fleet and transferring to undisclosed buyers. The ships have been sold in pairs, with the S-Class Maasdam and Veendam transferring to one company in August, while the R-Class Amsterdam and Rotterdam will move to another company in fall. Holland America Line will cancel cruises for the four ships' deployments, with some select itineraries being assumed by other ships in the fleet. The 2021 Grand World Voyage aboard Amsterdam will be postponed until 2022 and will now sail aboard Zaandam. The Grand Africa Voyage departing Oct. 10, 2021, aboard Rotterdam will also sail aboard Zaandam on the same dates. "It's always difficult to see any ship leave the fleet, especially those that have a long and storied history with our company," said Stein Kruse, CEO of Holland America Group and Carnival UK. "However, Holland America Line has a bright future ahead that includes recent Pinnacle-Class additions, with a third sister ship next year that will continue to maintain our overall capacity in the marketplace."

13:36 EDT Principia jumps after Bloomberg says Sanofi exploring potential buyout - Sanofi (SNY) is studying potential acquisitions of U.S. biotechnology companies including Principia Biopharma (PRNB) in an effort to obtain treatments for clinical areas such as multiple sclerosis and immune disorders, Bloomberg reports, citing people with knowledge of the matter said. Sanofi is working with advisers to study potential deals, sources told Bloomberg. The company already has a partnership with Principia, whose stock halted for volatility after jumping well off the day's lows following the report. It halted down 3% to $72.14.

13:10 EDT Williams-Sonoma pays $1M to FTC for made in the USA claims - Following a public comment period, the Federal Trade Commission has approved a final consent order settling charges that Williams-Sonoma "made false, misleading, or unsubstantiated claims" that all of its Goldtouch Bakeware products, its Rejuvenation-branded products, and Pottery Barn Teen and Pottery Barn Kids-branded upholstered furniture products are all or virtually all made in the United States. First announced in March 2020, the FTC's complaint alleged that Williams-Sonoma "deceptively claimed in advertisements and promotional materials that certain categories of its products were all or virtually all made in the United States." Under the terms of the final order, Williams-Sonoma is required to pay $1M to the FTC. The company also is prohibited from making "unqualified U.S.-origin claims for any product." Reference Link

13:07 EDT Retractable Technologies VP Kuhlman sells over $252K in company shares - Retractable Technologies VP Russell Kuhlman disclosed that he had sold 26,000 shares of company stock at $9.72 per share on July 16 for a total transaction amount of $252,720.

13:00 EDT PPG raises quarterly dividend 6% to 54c per share - The board of directors of PPG approved a 3c per share increase in the company's dividend, declaring a regular quarterly dividend of 54c per share, payable Sept. 11 to shareholders of record Aug. 10. PPG's prior quarterly dividend was 51c per share.

12:34 EDT Applied DNA spikes on patent for non-plasmid derived DNA vaccines - Shares of Applied DNA Sciences spiked after the United States Patent and Trademark Office posted a patent for non-plasmid derived DNA vaccines comprised solely of enzymatically produced amplicon expression vectors and their method of use to elicit antigen-specific immune responses in a subject. The shares are up 19% to $9.57 in midday trading. Reference Link

12:01 EDT Uber acquires public transit software firm Routematch - Uber is acquiring Routematch to support cities in providing more accessible public transportation. The companies said in an earlier blog posting: "Uber has been partnering with public transportation agencies around the world since 2015 to build more efficient, accessible, and equitable public transportation networks for the millions who depend upon them. Our shared vision of making individual car ownership a thing of the past has inspired innovative products and first- and last-mile solutions in cities across the globe. And while we've made a lot of progress together, more is needed, especially during these current times. Today, we're taking a big step forward in making our shared vision a reality. We're excited to announce that Uber has acquired Routematch, an industry-leading software provider serving more than 500 transit agency partners in urban, suburban, and rural communities around the world. With over two decades of experience, Routematch has partnered with large and small transit agencies, starting locally in the U.S. and expanding globally. With some of the longest-tenured relationships in the industry, the company is trusted to deliver accessible and inclusive technologies for riders of all abilities. Its mission is creating sustainable mobility ecosystems that leave no person behind. This acquisition brings together Uber's expertise in on-demand, global mobility technologies with Routematch's proven capabilities across paratransit, payments, fixed-route tools, and trip planning services. Both companies believe it will create new innovations that make it easier for agencies to provide the right transportation solutions to their riders, through an expanded suite of technologies. " Terms of the deal were undisclosed. Reference Link

12:00 EDT Youdao falls -8.5% - Youdao is down -8.5%, or -$3.29 to $35.41.

12:00 EDT Dell Technologies rises 13.8% - Dell Technologies is up 13.8%, or $7.26 to $59.95.

12:00 EDT Itau Corpbanca rises 34.0% - Itau Corpbanca is up 34.0%, or $1.36 to $5.36.

11:52 EDT NAD recommends Verizon discontinue certain 5G claims - The National Advertising Division, an organization that is part of BBB National Programs, determined that, in the context of two television commercials touting Verizon's rollout of 5G service in cities across the country, challenged by AT&T Services (T), certain express and implied claims regarding the breadth of Verizon's (VZ) 5G coverage and typical speeds potentially communicate a misleading message to consumers. NAD recommended that Verizon discontinue claims which communicate: 1. That its 5G service is widely available in cities across the country, and 2. That its service is broadly and readily accessible in cities where it has been launched. NAD also recommended that the advertiser discontinue claims implying that the speeds referenced in the commercials are typically experienced by consumers. NAD noted that the challenged advertising consists of shifting images of Verizon engineers describing the exceptional speed and capacity of Verizon's 5G network while standing in geographically diverse cities throughout the UnitedStates, with several running real-time speed tests on their phones.& NAD determined that while the challenged advertising communicates the accurate message that Verizon is building its 5G network, the commercials simultaneously tout the current performance of the network, ultimately conveying the net impression that Verizon's "ultrafast" 5G network is widely available in cities across the country and, where it has already been launched, is broadly and readily accessible to consumers. Reference Link

11:44 EDT Microsoft says Xbox Game Pass users to have free xCloud access in September - Microsoft announced that this September, in supported countries, it is bringing Xbox Game Pass and Project xCloud together at no additional cost for Xbox Game Pass Ultimate members. "With cloud gaming in Game Pass Ultimate, you will be able to play over 100 Xbox Game Pass titles on your phone or tablet," the company said. "And because Xbox Live connects across devices, you can play along with the nearly 100 million Xbox Live players around the world. So when Halo Infinite launches, you and your friends can play together and immerse yourselves in the Halo universe as Master Chief-anywhere you go and across devices. Cloud gaming in Xbox Game Pass Ultimate means your games are no longer locked to the living room. You can connect more than ever with friends and family through gaming. And just like you do with your movie and music streaming services, when cloud gaming launches into Xbox Game Pass Ultimate, you can continue your game wherever you left off on any of your devices."

11:33 EDT Gold Standard announces partnership with Orion Mine Finance for $22.5M - Gold Standard Ventures announced they have entered into a binding letter of intent with Orion Mine Finance relating to a series of transactions, totaling approximately $22.5M. Concurrently with the execution of the binding letter of intent, Orion has agreed to acquire $748,031 in common shares of the Company through market purchases and has purchased an additional 17,662,646 Gold Standard Common Shares at C$1.12 per share for a total of $14.62M from an existing shareholder. Pursuant to the Orion Transactions, Orion has committed to purchase an additional $5,135,326 of Gold Standard Common Shares through a non-brokered private placement at C$1.05 per share. Additionally, the Company and Orion will enter into a silver streaming agreement for 100% of the silver production on the Company's South Railroad project in Nevada, U.S.A and at the Jasperoid Wash deposit, which is a limited portion of the lands owned or controlled by the Company. Finally, Orion has agreed to provide a proposal for up to $200M of financing support to the Company to help finance the construction of the South Railroad Project following the satisfaction of certain milestones. Pursuant to the Orion Equity Investment, Orion has agreed to purchase $748,031 of Gold Standard Common Shares through market purchases. Orion has also purchased an additional 17,662,646 Gold Standard Common Shares at C$1.12 per share for a total $14.62M from an existing GSV shareholder. Orion has also committed to purchase an additional 6,619,191 Gold Standard Common Shares at a price per share of C$1.05 for aggregate proceeds of $5,135,326 to the Company. Upon entering into the Silver Streaming Agreement, Orion will purchase 100% of the silver production from the South Railroad Project and the Jasperoid Wash deposit for the life of mine at a price of 15% of the prevailing market price for silver. In connection with the Silver Stream, Orion will make a deposit to the Company of $2M. The Silver Stream will be guaranteed by the Company and its direct and/or indirect subsidiaries that own the South Railroad Project and the Jasperoid Wash deposit. Pursuant to the Financing Support, Orion has agreed to provide the Company with a term sheet to provide up to $200M of financing support to the Company, following the satisfaction of mutually agreed milestones, to help finance the construction of the South Railroad Project. In connection with the Financing Support, Orion shall be granted a right of first offer on any financial instrument for financing the Company including, but not limited to, streaming, royalty, prepay or offtake agreements for precious metals of the Company. Orion's right of first offer does not include any bought or overnight marketed equity or convertible debt deal with banks or brokers, project finance, term loans or a credit facility by a bank or syndicate of banks, a marketed high yield offering underwritten by a bank, and any financing transaction with aggregate proceeds of up to $40M. Closing of the Orion Transactions is subject to the execution of definitive documentation, satisfaction of conditions precedent and regulatory approvals.

11:24 EDT Walgreens Boots Alliance collaborates with DoorDash for on-demand delivery - Walgreens and DoorDash announced a new collaboration to offer on-demand delivery to customers in select cities with plans to expand to markets throughout the country. The companies said in a release, "Customers in the Chicago, Atlanta and Denver areas can order on-demand delivery from Walgreens through the DoorDash app and website, selecting from an assortment of more than 2,300 convenience, health and wellness items. By the end of summer 2020, Walgreens and DoorDash plan to offer more than 5,000 items for delivery on the DoorDash platform, and will expand the service to other major markets starting with Cincinnati, Cleveland, Minneapolis, Oklahoma City, Phoenix, Sacramento and Seattle. Items available for delivery in the Chicago, Atlanta and Denver areas include select over-the-counter medications, and other household essentials and convenience products from Walgreens stores."

10:46 EDT Twitter confirmed internal tools accessed for hacks - Twitter last night commented on its investigation into the high profile account hacks: "We detected what we believe to be a coordinated social engineering attack by people who successfully targeted some of our employees with access to internal systems and tools. We know they used this access to take control of many highly-visible (including verified) accounts and Tweet on their behalf. We're looking into what other malicious activity they may have conducted or information they may have accessed and will share more here as we have it. Once we became aware of the incident, we immediately locked down the affected accounts and removed Tweets posted by the attackers. We also limited functionality for a much larger group of accounts, like all verified accounts (even those with no evidence of being compromised), while we continue to fully investigate this. This was disruptive, but it was an important step to reduce risk. Most functionality has been restored but we may take further actions and will update you if we do. We have locked accounts that were compromised and will restore access to the original account owner only when we are certain we can do so securely. Internally, we've taken significant steps to limit access to internal systems and tools while our investigation is ongoing. More updates to come as our investigation continues."

10:32 EDT Synchrony announces multi-year partnership with Club Champion - Synchrony announced a new, multi-year program agreement enabling Club Champion's customers to continue to access special financing offers. "The new agreement comes just ten months after the two companies announced their extension of a special financing program for Club Champion customers who use the Synchrony Sport Card," the companies said.

10:20 EDT Health Canada authorizes interim use of DexCom G6 CGM by pregnant women - Health Canada temporarily authorized the adjunctive use of the Dexcom G6 Continuous Glucose Monitoring system by pregnant women with Type 1, Type 2, or gestational diabetes. This temporary expanded indication was granted because of the active role Dexcom CGM can play in the treatment and mitigation of COVID-19 by significantly reducing the in-person interaction between pregnant women with diabetes and healthcare providers, reducing potential exposure to the virus. Health Canada's temporary expanded indication for the adjunctive use of Dexcom G6 by pregnant women will be in place until March 18, 2021, unless the authorization requires changes within that timeframe. Health Canada has updated its website to include a list of the approved CGM systems along with additional safety statements.

10:00 EDT Carnival falls -8.3% - Carnival is down -8.3%, or -$1.45 to $16.03.

10:00 EDT Norwegian Cruise Line falls -11.0% - Norwegian Cruise Line is down -11.0%, or -$2.04 to $16.46.

10:00 EDT Lannett rises 19.6% - Lannett is up 19.6%, or $1.01 to $6.15.

09:52 EDT CVS Health requires all customers to wear face coverings, effective July 20 - CVS Health COO Jon Roberts provided the following update on the use of face coverings at CVS Pharmacy locations: "Since the pandemic began, we've done everything we can to keep people safe and healthy. This includes requiring that store employees wear face coverings and encouraging our customers to do so as well. In any community with state or local laws mandating the use of face coverings, we've made that very clear through signage and other reminders. With the recent spike in COVID-19 infections, we're joining others in taking the next step and requiring all customers to wear face coverings when entering any of our stores throughout the country effective Monday, July 20. To be clear, we're not asking our store employees to play the role of enforcer. What we are asking is that customers help protect themselves and those around them by listening to the experts and heeding the call to wear a face covering."

09:47 EDT Mogu falls -8.5% - Mogu is down -8.5%, or -29c to $3.13.

09:47 EDT Itau Corpbanca rises 7.5% - Itau Corpbanca is up 7.5%, or 30c to $4.30.

09:47 EDT Lannett rises 20.0% - Lannett is up 20.0%, or $1.03 to $6.17.

09:23 EDT Kirkland Lake Gold extends suspension of operations at Holt Complex - Kirkland Lake Gold announced that the suspension of operations at the Company's Holt Complex, in effect since April 2, 2020, will be extended until further notice. The Company suspended business activities at the Complex as part of its COVID-19 protocols, and at the same time continued with a strategic review to assess a potential restart of the operations. The Holt Complex, including the Holt, Taylor and Holloway mines and Holt Mill, was designated as non-core by the Company on February 19, 2020 with the Company planning to consider all options to maximize the value of the assets. The Complex's high cost structures, low grades, diminishing reserves and requirements for new investments have resulted in significant negative cash flows from these operations, and are key drivers of our decision to extend the suspension of business activities.

09:22 EDT Tyler Technologies adds Johnson County to statewide agreement for its solutions - Tyler Technologies announced that it has signed an agreement with the Kansas judicial branch to add the 10th Judicial District Court in Johnson County as an additional court to its statewide agreement for Tyler's Odyssey case management and Tyler Supervision solutions. Tyler will provide its full Odyssey court solution suite, as well as Tyler Supervision, for the 10th Judicial District Court's civil, criminal, traffic, juvenile and family case types. Tyler initially signed a statewide agreement with the Kansas judicial branch in December 2017, which excluded Johnson County. Johnson County had been using a legacy software solution, and it did not make sense at the time to transition the software to Odyssey. However, following the contract signing and with the support of the Kansas Supreme Court, the Kansas judicial branch and the 10th Judicial District Court in Johnson County elected to add Johnson County to the existing statewide contract for Odyssey, also selecting Tyler Supervision to be used across the state. In total, 105 counties will use both solutions for case management and supervision services. The 10th Judicial District Court will transition from its legacy case management solution to Odyssey, enabling the court to soon become fully integrated with the rest of the state.

09:19 EDT Vystar Corp to produce RxAir400 UV-C light air purifiers with new manufacturer - Vystar Corporation has restarted production of its RxAir400 Ultraviolet light air purification systems with a new manufacturer that will enable enhanced reliability for supply chain, production and delivery. RxAir400 is a smaller, consumer/small business-sized version of the industrial size Rx3000 FDA-certified Class II medical device UV light air purifier designed for disinfection use in hospitals. Vystar anticipates receiving the first shipment of 10,000 RxAir400 units and replacement bulb cartridges from the new manufacturer in approximately 45 days. Vystar is currently taking pre-orders on its RxAir.com website. It has received cash deposits on pre-orders of approximately $1 million of RXAir products at retail.

09:18 EDT Johnson & Johnson expects COVID-19 shot to reach 70%-80% efficacy

09:17 EDT Banner Health adds Cerner's Revenue Cycle Management - Banner Health and Cerner Corporation have expanded their relationship to implement an end-to-end, comprehensive suite of revenue cycle management solutions, building on a multi-year, long-standing strategic alignment using health care technology to drive population health improvement. The revenue cycle integration is designed to streamline and simplify the clinician and patient experience across Banner Health's entire system, including 28 hospitals and clinics in six states.

09:14 EDT Sono-Tek announces $1.5M order for electronics/microelectronics industry - Sono-Tek announced that it has received a significant new order for a 6-axis coating system for the Electronics/Microelectronics industry that is valued at approximately $1.5M. The order is among the largest that the Company has received in its history and is for a highly engineered proprietary 6-axis ultrasonic coating system for an important European customer. Sono-Tek's applications engineering team has worked closely with the customer to ensure that the best possible solution is engineered and built according to the customer's requirements.

09:08 EDT The ODP Corporation announces new graphic design collaboration with Canva - Office Depot, a wholly owned subsidiary of The ODP Corporation, announced a new collaboration with Canva. Canva's graphic design solutions paired with the printing services offered on officedepot.com are now available to help small business customers keep business going during this pivotal time. The new collaboration integrates Canva's drag-and-drop design interface found on officedepot.com's print services section. Small business owners can now create professional marketing materials like flyers and posters to let their community know that they are open for business. Customers can also access royalty-free photography along with tools such as frames, shapes, fonts and thousands of color options where small businesses can get approximate matches to their brand standards.

09:07 EDT Scynexis announces one-for-ten reverse stock split - SCYNEXIS announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-10. The effective time of the reverse stock split will be 12:01 a.m. ET on July 17, 2020. SCYNEXIS common stock will begin trading on a split-adjusted basis commencing upon market open on July 17, 2020. At SCYNEXIS's annual meeting of stockholders held on July 2, 2020, stockholders voted to approve a proposal to effect a reverse stock split and reduce the number of authorized shares of SCYNEXIS's common stock from 250 million shares to 100 million shares. Accordingly, on July 17, 2020, the number of authorized shares of SCYNEXIS's common stock will be 100 million shares. As a result of the reverse split, every 10 shares of SCYNEXIS's issued and outstanding common stock will be automatically combined and converted into one issued and outstanding share of common stock, par value $0.001 per share. SCYNEXIS's common stock will continue to trade on the Nasdaq Global Market under the symbol "SCYX," but will be assigned a new CUSIP number, 811292 200. The reverse stock split reduces the number of shares of common stock issuable upon the conversion of SCYNEXIS's outstanding convertible notes and the exercise or vesting of its outstanding stock options, restricted stock units and warrants in proportion to the ratio of the reverse stock split and causes a proportionate increase in the conversion and exercise prices of such convertible notes, stock options and warrants.

09:05 EDT Fifth Third announces strategic relationship with Trust & Will - Fifth Third and Trust & Will announced a new strategic relationship to further help Fifth Third's customers protect and secure their families' financial future. Fifth Third customers will be able to prepare an estate plan online through Trust & Will and will have access to discounted pricing. Trust & Will is a fintech in the digital estate planning business that provides way to create, store and share wills, guardianships and trusts.

09:03 EDT BofA: NII stability to be dependent on asset growth, redeployment of deposits

09:02 EDT STMicroelectronics signs two M&A agreements to acquire BeSpoon, Riot Micro - STMicroelectronics announced the signing of two M&A agreements related to the acquisitions of the entire share capital of Ultra Wide Band specialist BeSpoon and of the cellular IoT connectivity assets of Riot Micro. After closing of the two transactions, subject to customary regulatory approvals, ST will further strengthen its offer for wireless connectivity and, in particular, the roadmap for its STM32 microcontrollers and secure MCUs. BeSpoon, based in Le Bourget du Lac, France, is a fabless semiconductor company founded in 2010 and specialized in Ultra Wide Band communications technology. Their technology enables secure real-time indoor location with centimeter accuracy in environments under adverse conditions. The integration of this key secure positioning technology in the STM32 product portfolio will enable developers of IoT, automotive and mobile communication applications to provide services such as secure access, and precise indoor & outdoor mapping. ST will acquire BeSpoon from its majority shareholder, TRUMPF, and from its founders. In parallel with the transaction, ST and TRUMPF will enter into a strategic partnership for UWB tracking technology. Riot Micro, based in Vancouver, Canada, designs cellular IoT solutions by applying proven design techniques from Bluetooth Low Energy and Wi-Fi to LTE Cat-M and NB-IoT to optimize system cost and power. The integration of cellular communication capabilities into the STM32 portfolio will strengthen ST's offer for customers developing applications such as asset tracking, metering, and fleet management services. The terms of the transactions were not disclosed.

08:49 EDT Neogen plans to acquire U.S. rights and assets to Elanco's insecticide - Neogen (NEOG) plans to acquire the U.S. rights to Elanco's StandGuard Pour-on for horn fly and lice control in beef cattle, and related assets. Closing remains subject to a final FTC consent decree for closing of Elanco's acquisition of Bayer AG's global animal health business. Neogen entered the agricultural insecticide market with its 2014 acquisition of Chem-Tech. Terms of the agreement were not disclosed.

08:48 EDT Thermo Fisher raises cash offer for Qiagen to EUR43.00 from EUR39.00

08:47 EDT Thermo Fisher boosts Qiagen offer price to EUR 43 per share from EUR 39

08:44 EDT Johnson & Johnson says medical devices hit hardest in Q2, sees recovery in Q4 - Sees above market growth in Pharmaceutical segment in FY20.

08:43 EDT Morgan Stanley: No plans to radically shrink real estate

08:42 EDT Allstate reports June estimated catastrophe losses of $204M - Allstate announced estimated catastrophe losses for the month of June of $204M, pre-tax, $161 million, after-tax. Allstate said in a release, "Catastrophe losses occurring in June comprised ten events at an estimated cost of $181 million, pre-tax ($143 million, after-tax), plus unfavorable prior period reserve reestimates. Three severe wind and hail weather events, primarily impacting Texas, Pennsylvania and Alberta (Canada), accounted for approximately 50% of June estimated catastrophe losses. Allstate previously announced $982 million, pre-tax ($776 million, after-tax), in estimated catastrophe losses for the months of April and May 2020, bringing estimated catastrophe losses for the second quarter 2020 to $1.19 billion, pre-tax ($937 million, after-tax)."

08:40 EDT Open Lending certifies over 18,680 loans in Q2 - Open Lending Corporation announced it certified over 18,680 loans in the second quarter 2020, of which, approximately 7,100 loans were certified in the month of June. The second quarter 2020 certs represent a 39% increase to the midpoint of the revised guidance and ahead of the high end of the revised guidance for the quarter. Open Lending's certification volume is up 26% year-to-date. John Flynn, CEO and President of Open Lending commented, "We continued to see momentum in our certification volumes throughout June as markets began to open up. These results were ahead of our revised guidance for the quarter, primarily driven by pent up demand and increased used car sales as commuters are reluctant to take public transportation. Lenders have been resilient with our current partners continuing to utilize our platform and we have added 28 new lenders onto the platform year-to-date, resulting in a net increase in lenders over the same period."

08:39 EDT JetBlue, American Airlines enter strategic partnership for Northeast customers - JetBlue (JBLU) and American Airlines (AAL) announced a strategic partnership that will create connectivity for travelers in the Northeast and more choice for customers across their domestic and international networks. In addition, the companies said the relationship will accelerate each airline's recovery as the travel industry adapts to new trends as a result of the pandemic. The partnership includes an alliance agreement that proposes codeshare and loyalty benefits that will enhance each carrier's offerings in New York and Boston. The partnership enables new strategic growth opportunities for both airlines. As a result, American will launch international service from New York to Tel Aviv and to Athens and JFK to Rio De Janeiro will return as a daily seasonal route in winter 2021, in addition to continuing to serve long-haul destinations like London and Madrid. JetBlue will also accelerate its growth in key cities, bringing its service to more customers. JetBlue will grow in greater New York City, adding flights at LaGuardia and Newark, while also increasing its presence at JFK for connections to American's expanded international network. JetBlue plans to enhance service to markets on the East Coast, West Coast, and in the Southeast, building on JetBlue's recently announced service between Newark and nine markets, including Mint service to Los Angeles and San Francisco . Through their integrated networks, JetBlue and American will operate reciprocal codeshare flights, giving customers new options with improved schedules, competitive fares and nonstop access to more domestic and international destinations. JetBlue will gain connectivity to more U.S. destinations, a broad global network and an improved frequent flyer proposition, while American will complement JetBlue's improved and expanded service with new international routes. JetBlue and American loyalty members will also enjoy new benefits while the carriers are exploring additional premium experiences for customers.

08:37 EDT Heron Therapeutics initiates Phase 2 clinical study of Cinvanti for COVID-19 - Heron Therapeutics initiated the GUARDS-1 Study, a Phase 2 clinical study evaluating Cinvanti injectable emulsion in early hospitalized patients with COVID-19. The study initiation follows clearance from the FDA of Heron's Investigational New Drug application for Cinvanti for the treatment of COVID-19. Cinvanti is an intravenous formulation of aprepitant, a receptor antagonist approved for use for the prevention of chemotherapy-induced nausea and vomiting in patients with cancer. COVID-19 is associated with lower respiratory tract inflammation that often progresses to Acute Respiratory Distress Syndrome, itself associated with high mortality. GUARDS-1 is a Phase 2 study designed to investigate the efficacy and safety of adding daily dosing of CINVANTI for 14 days as a 2-minute intravenous injection to standard of care to reduce mortality and the need for assisted ventilation in early hospitalized adult patients with a confirmed SARS-CoV-2 infection.

08:33 EDT JetBlue, American Airlines form strategic partnership for Northeast customers - JetBlue Airways (JBLU) and American Airlines Group (AAL) announced a strategic partnership that will create seamless connectivity for travelers in the Northeast and more choice for customers across their complementary domestic and international networks. In addition, the relationship will accelerate each airline's recovery as the travel industry adapts to new trends as a result of the pandemic. The partnership includes an alliance agreement that proposes codeshare and loyalty benefits that will enhance each carrier's offerings in New York and Boston, providing strategic growth and driving value for customers and team members of both airlines. Customers will experience a number of benefits from the new partnership, including: New and expanded routes: The partnership enables new strategic growth opportunities for both airlines. As a result, American will launch international service from New York to Tel Aviv and to Athens, and JFK to Rio De Janeiro will return as a daily seasonal route in winter 2021, in addition to continuing to serve popular long-haul destinations like London and Madrid. JetBlue will also accelerate its growth in key cities, bringing its award-winning service to more customers. JetBlue will grow in greater New York City, adding flights at LaGuardia and Newark, while also increasing its presence at JFK for seamless connections to American's expanded international network. JetBlue plans to enhance service to strategic markets on the East Coast, West Coast, and in the Southeast, building on JetBlue's recently announced service between EWR and nine markets, including Mint(R) service to Los Angeles and San Francisco. More choice and loyalty benefits: Through their integrated networks, JetBlue and American will operate reciprocal codeshare flights, giving customers new options with improved schedules, competitive fares and nonstop access to more domestic and international destinations. JetBlue will gain connectivity to more U.S. destinations, a broad global network and an improved frequent flyer proposition, while American will complement JetBlue's improved and expanded service with new international routes. JetBlue and American loyalty members will also enjoy new benefits while the carriers are exploring additional premium experiences for customers. Seamless experience: Customers will enjoy a seamless experience across both airlines, including the ability to book a single itinerary on either website, convenient connections and an improved on-the-ground experience - resulting in a compelling proposition for both leisure and corporate customers. Additionally, customers seeking more comfort in transcontinental service will have access to both JetBlue's Mint and American's three-class Transcon service. JetBlue is not joining oneworld or the AA/IAG Atlantic Joint Business Agreement and will continue with plans to independently launch and operate transatlantic flights to London in 2021. The implementation of the alliance agreement and other arrangements described herein is subject to governmental review.

08:32 EDT Johnson & Johnson says long term fundamentals 'remain strong' - Says capital allocation "remains intact."

08:28 EDT Tracon Pharmaceuticals files protocol for ENVASARC trial with FDA - TRACON Pharmaceuticals announced the filing of the pivotal ENVASARC protocol with the U.S. Food and Drug Administration as part of an Investigational New Drug application. The application cross references the open envafolimab IND maintained by TRACON's corporate partners 3D Medicines and Alphamab Oncology. TRACON previously reported results of a May 8 teleconference with the FDA whereby the agency agreed with TRACON's proposals regarding key elements of the pivotal ENVASARC trial for envafolimab in the soft tissue sarcoma subtypes of undifferentiated pleomorphic sarcoma and myxofibrosarcoma. TRACON expects to initiate enrollment in the ENVASARC trial at 25 sites in the U.S. in the second half of 2020. Key elements for the ENVASARC pivotal trial include: Multi-center, open-label, randomized, non-comparative, parallel cohort study. Eligible patients will have received one or two prior cancer therapies, but no prior immune checkpoint inhibitor therapy. Planned total enrollment of 160 patients, with 80 patients enrolled into cohort A of treatment with single agent envafolimab and 80 patients enrolled in cohort B of treatment with envafolimab and Yervoy. Primary endpoint of objective response rate with duration of response a key secondary endpoint. Open-label format with blinded independent central review of efficacy endpoint data.

08:25 EDT Emmaus Life Sciences engages Partner International for Endari out-licensing - Emmaus Life Sciences announced that it has engaged Partner International to lead the out-licensing activity for Emmaus' prescription grade L-glutamine oral powder for use in the treatment of diverticulosis. This is the same active pharmaceutical ingredient found in Endari, which is approved by the FDA and the Israeli Ministry of Health to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Diverticulosis is an often asymptomatic gastrointestinal condition affecting a large segment of the adult populations in the U.S. and elsewhere. It can sometimes progress to diverticulitis, a debilitating GI disease that often requires hospitalization and on occasion surgical intervention. Based upon limited clinical results suggesting that Endari(R) may be effective in slowing and reversing the progression of diverticulosis, in April 2019 Emmaus commenced a Pilot/Phase 1 study of its PGLG oral powder to evaluate the change in the number and size of colonic diverticula and assess safety in 10 to 15 patients at multiple study sites. A preliminary interim evaluation of the first patients in the study indicates consistently positive results. Although the trial is ongoing, based upon the data obtained so far, Emmaus would intend to pursue a Phase III trial under the FDA's abbreviated 505(b)(2) regulatory pathway.

08:24 EDT Johnson & Johnson continues to invest in R&D at 'competitive levels'

08:24 EDT Morgan Stanley continues to see FY20 core tax rate 22%-23%

08:22 EDT Just Energy announces slate of seven director candidates - Just Energy Group announced a slate of seven director candidates, of which five are new directors, who will be appointed to the board of directors upon completion of the previously announced recapitalization transaction. A special and annual meeting of Just Energy's securityholders is expected to be held to consider the recapitalization transaction on August 25, 2020. Just Energy announced on July 8, 2020 that it is undertaking a comprehensive plan to strengthen and de-risk the business, including a renewed Board to provide robust oversight and governance on behalf of stakeholders as well as a recapitalization transaction under the Canada Business Corporations Act that will significantly improve the Company's financial flexibility and liquidity. The Company has applied for an interim order from the Ontario Superior Court of Justice for the recapitalization transaction, which will be effected through a plan of arrangement under the CBCA. The interim order hearing is scheduled for the morning of July 17, 2020. The seven candidates include five new candidates and two incumbents. They possess a wide spectrum of skills and expertise, including deep knowledge of the energy industry. They are: James Bell, CEO of Founders Advantage Group, Anthony Horton, Chairman of the board of NanoLumens, Steven Murray, CEO of Primus Green Energy, Stephen Schaefer, a member of the board of Element Markets, Marcie Zlotnik, co-founder of StarTex Power, R. Scott Gahn, CEO of Just Energy,Dallas Ross, GP and Founder of Kinetic Capital Partners. Five of the seven candidates are independent of the Company. The exceptions are Mr. Gahn, the president and chief executive officer of Just Energy, and Mr. Horton, who has acted as a consultant to the Company since November 2019. Full biographies of all the candidates can be found below. IIn conjunction with the planned reconstitution of the Board, the Company announced that Rebecca MacDonald, the Company's founder, will be retiring and stepping down from the Board, effective today. At the same time, her employment contract as Executive Chair will be terminated by mutual agreement.

08:20 EDT Morgan Stanley sees NII drifting lower for rest of year

08:15 EDT Johnson & Johnson says China returned to growth in Q2, fueled by medical devices - Says Tylenol continues to see strong demand due to COVID-19. Says oncology portfolio delivered "strong" quarter. Comments taken from Q2 earnings conference call.

08:15 EDT Canacol Energy reports gas sales average 165 MMscfpd during June - Canacol Energy provides the following gas sales and drilling update. Realized contractual natural gas sales for June 2020 averaged approximately 165 million standard cubic feet per day. In addition to the realized contractual gas sales the Corporation saw an additional 12 to 14 MMscfpd of gas sales nominations throughout the second quarter, which must be paid for during the remainder of 2020 for which delivery timing is at the discretion of the off taker. Using the Pioneer 53 drilling rig the Pandereta 8 development well spud on June 27, 2020 and reached 9,524 feet measured depth on July 9, 2020. The well encountered 168 feet true vertical depth of net gas pay within the producing Cienega de Oro sandstone reservoir. The well is currently being completed and tied into the manifold to be placed on production. The rig will then be mobilized to spud the Pandereta 4 appraisal well during the first week of August 2020. The well will test a potential western extension of the Pandereta field and will take approximately 5 weeks to drill and complete. In June 2020 the Corporation contracted a second drilling rig, the Pioneer 302, which is currently being mobilized to spud the Porro Norte 1 exploration well located on its 100% operated VIM5 Exploration and Production contract. The well is anticipated to spud the third week of July 2020 and will take approximately 7 weeks to drill and test. Porro Norte 1 is probing a 4 way anticlinal structural closure defined on 2D seismic, and will target potential gas within the Porquero, CDO, and Cicucco sandstone and limestone reservoirs. The Porro Norte prospect is located approximately 25 kilometers to the north of the Pandereta field which produces from the CDO sandstone reservoir.

08:11 EDT Daxor announces prospective randomized control trial at Duke University - Daxor Corporation announced the initiation of a prospective randomized control trial utilizing Daxor's BVA-100 technology to guide volume treatment in heart failure patients. Duke University Medical Center has begun enrolling patients under the leadership of Marat Fudim, MD, MHS and G. Michael Felker, MD, MHS. This study follows Daxor's recent announcement of the initiation of a first-of-its-kind prospective multicenter BVA trial in hospitalized COVID-19 patients. Both trials highlight that volume derangements are common in a diverse set of medical conditions and are designed to add to the scientific body of evidence which has demonstrated the impact of Daxor's BVA test on improved patient care and outcomes. Daxor's BVA test has been associated with a reduction in heart failure 30-day mortality by 82%, 30-day readmissions by 56%, and 1-year mortality by 86% in a peer-reviewed study published in December 2018 in the Journal of the American College of Cardiology - Heart Failure titled "Heart Failure Outcomes With Volume Guided Management."

08:11 EDT Twist Bioscience, Invetx enter pact to engineer antibodies for pet diseases - Twist Bioscience and Invetx announced a partnership for the engineering and optimization of novel antibodies for the treatment of serious diseases in dogs and cats. Under the terms of the agreement, Twist Biopharma, a division of Twist Bioscience, will use its Twist Antibody Optimization, or TAO, platform to engineer and optimize multiple antibodies against disease targets in animal health. The Twist technology will be a key component of Invetx's antibody discovery effort and the company's strategy to develop safer and more effective veterinary medicines.

08:10 EDT Biocept board's reverse stock split proposal recommended by ISS, Glass Lewis - Biocept announced that independent, third-party proxy advisory firms ISS and Glass Lewis both have recommended that stockholders vote in favor of Biocept's proxy proposal to authorize a reverse stock split of Biocept's common stock. Biocept's board of directors has recommended a vote for the Proposal, which will authorize Biocept's board of directors to amend Biocept's Certificate of Incorporation to effect a reverse split of Biocept's common stock at a ratio in the range of 1:5 to 1:30, as determined by Biocept's board of directors. The reverse stock split proposal is intended to increase the per-share trading price of Biocept's common stock to satisfy the $1.00 minimum closing bid price requirement for continued listing on Nasdaq. Biocept has until December 7 to satisfy the Nasdaq $1.00 minimum closing bid requirement. Voting on the Proposal will be open through the conclusion of Biocept's 2020 Annual Meeting of Stockholders, which will reconvene on July 31.

08:09 EDT InnerWorkings to be acquired by HH Global for $3.00 per share - InnerWorkings and HH Global Group announced that they have signed a definitive agreement to combine operations. The companies said in a release, "Under the terms of the agreement, HH Global will acquire InnerWorkings for $3.00 per share in an all-cash transaction representing approximately $177 million in equity value. This represents a premium of 127% to the closing price, and a premium of 104% to the 90-day volume weighted average price as of July 15, 2020. The transaction has been unanimously approved by the Boards of Directors of both companies. The combination will result in a world-class marketing engineering and execution firm that is well-positioned to serve global clients seeking innovative, end-to-end marketing solutions that lower costs and improve brand consistency, visibility, sustainability and speed to market. With complementary offerings and capabilities, InnerWorkings' leading North American position and HH Global's strong leadership presence in EMEA and APAC, the combined company will operate with global reach and scale, maintaining the agility and client-focused execution that is core to both InnerWorkings and HH Global's strategic approach. Together, the two companies will have a stronger operating model and balance sheet and will be well-positioned to continue InnerWorkings' transformation and to build and maintain long-term client relationships as a true first-choice partner for leading brands. In addition, the combined company will benefit from the support of funds managed or advised by Blackstone Tactical Opportunities, an existing strategic minority equity investor in HH Global. Under the terms of the merger agreement, HH Global will acquire all of the outstanding shares of InnerWorkings common stock for $3.00 per share in cash which represents a premium of 127% to the closing price and a premium of 104% to the 90-day volume weighted average price as of July 15. The transaction is subject to customary closing conditions, including approval by InnerWorkings' shareholders and receipt of certain regulatory approvals, and is expected to be completed before the end of Q4."

08:07 EDT Rhythm announces publication of results from Phase 2 study of setmelanotide - Rhythm Pharmaceuticals announced that results from its Phase 2 study evaluating setmelanotide for the treatment of obesity and insatiable hunger, known as hyperphagia, in patients living with Bardet-Biedl Syndrome were published in the peer-reviewed journal Diabetes, Obesity and Metabolism. As previously reported, data from the study demonstrate that treatment with setmelanotide, the company's melanocortin-4 receptor agonist, reduced body weight and hunger in individuals with BBS. Rhythm initially reported topline data from its Phase 2 Basket Study of setmelanotide in BBS in June 2018 and most recently, in September 2019, Rhythm announced updated data following approximately two years on therapy. The Phase 2 study participants received a daily subcutaneous injection of setmelanotide. The dose was titrated every two weeks for up to 12 weeks to establish the individual dose. The primary outcome was mean percent change from baseline in body weight at three months. Mean percent change in body weight was also assessed after six and 12 months of treatment as additional exploratory efficacy outcomes. Change in hunger scores, metabolic parameters, and safety were secondary outcomes. As announced in December 2019, Rhythm completed enrollment of the pivotal cohort in its Phase 3 clinical trial evaluating setmelanotide for the treatment of hyperphagia and severe obesity in individuals living with BBS or Alstrom syndrome. This Phase 3 trial enrolled 32 individuals with BBS and six individuals with Alstrom syndrome in the pivotal cohort, and Rhythm has continued to enroll patients in a supplemental cohort to meet demand and provide further data on the use of setmelanotide in people living with BBS or Alstrom syndrome. The company expects to report topline data from the pivotal Phase 3 trial evaluating setmelanotide in BBS and Alstrom syndrome in the fourth quarter of 2020 or early in the first quarter of 2021.

08:07 EDT Leaf Group investor group comments on board member resignation - Investors owning over 40% of the issued and outstanding shares of Leaf Group, responded to the Form 8-K filed yesterday disclosing that Mitchell Stern resigned on July from the Leaf Group board and that the board has been forced to reconstitute the audit committee to remove Charles Baker, whom it belatedly recognized is not an independent director under NYSE rules. The investor group includes Osmium Partners, PEAK6 Investments, Boyle Capital, Oak Management, Generation Capital Partners II LP, Generation Partners II LLC, Spectrum Equity Investors V, L.P. and Spectrum V Investment Managers' Fund and is comprised of several of the company's largest and longest-standing shareholders. The Investor Group stated: "Mr. Stern is the third director to resign from Leaf Group this year. We can only assume that Mr. Stern is as frustrated with the Board's failure to address the governance shortcomings and lack of leadership at Leaf Group as we are. We again call on the remaining Board members to fulfill their fiduciary obligations to shareholders - and to put the best interests of those shareholders first - rather than defending CEO Sean Moriarty in the face of overwhelming evidence that he has abused his position as CEO and lost his mandate from shareholders to lead the Company... This Company's failure to identify and disclose conflicts of interest demonstrates a lack of care and transparency. Its continued support of a failed leader in the face of widespread shareholder opposition is worse: it elicits questions as to whether the individual Board members are in breach of each of their fiduciary duties. We remind this Board that shareholders who own more than 50% of the stock have spoken publicly and expressed a desire for significant change. This is a clear message that the Board does not currently have a mandate from its shareholders. Given this lack of confidence, the current directors must refrain from filling Mr. Stern's vacant seat without a majority of shareholders being consulted and being part of the process. We also encourage the remaining directors to seek independent legal counsel. A culture of conflicts has permeated the Company and needs to be reversed. We are confident that objective professionals will advise the directors of their obligation to act as fiduciaries and to listen to Leaf Group's shareholders, remove Mr. Moriarty, augment the Board with new independent directors in consultation with shareholders and run a genuine strategic alternatives process led by a truly independent director. The Board cannot cover its eyes and ears, hoping Leaf Group's shareholders will ignore the directors' troubling history, non-compliance with applicable rules and misleading statements. To protect shareholder value, it is incumbent upon the Board to listen to shareholders' perspective and act in accordance with their interests. The conduct of the incumbent Board members over the next several weeks will definitively determine if these directors will be remembered as the villains or the heroes of this story."

08:06 EDT Morgan Stanley: It will be 'challenging' to meet 1H results - Comments taken from Q2 earnings conference call.

08:06 EDT FLIR Systems awarded $21.8M production contract - FLIR Systems announced it has been awarded a full-rate production option worth $21.8 million on an indefinite-delivery/ indefinite-quantity, or IDIQ, contract with the United States Army. FLIR Systems said in a release, "FLIR will deliver its Agentase C2 disclosure spray to detect G- and V-series nerve agents, highly toxic chemical warfare agents. The contract will support the Army's Contamination Indicator/Decontamination Assurance System, or CIDAS, program, a 'program of record' within the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense, or JPEO-CBRND. FLIR Agentase C2 spray quickly changes color on a surface if a chemical warfare agent is present. With faster and more targeted detection, military decontamination experts can locate trace levels of contamination and precisely mitigate the threat. The original IDIQ contract dates to 2015 and consisted of an engineering and manufacturing development phase, followed by low-rate initial production phase. This latest award initiates the full-rate production phase. Shipments are expected to begin in the fourth quarter of 2020. The contract is expected to be completed in 2025. FLIR is currently supporting two efforts by JPEO-CBRND to field the Agentase C2 product line to the Joint Services under CIDAS. In September 2019, FLIR announced a $35.1 million contract with the U.S. Army to deliver its disclosure spray formulated for blister agents such as sulfur mustard."

08:04 EDT MYOS settles litigation with RENS Technology - MYOS has settled its pending litigation with RENS Technology and its president. As part of the settlement, the parties have agreed to dismiss the pending litigation between them and have exchanged mutual releases. In addition, RENS has agreed to vote all of its shares of common stock of MYOS in favor of the proposed merger between MYOS and MedAvail pursuant to the Agreement and Plan of Merger and Reorganization entered into on June 30. RENS has also waived its right to receive an ownership interest in the new private company focused on muscle health that will be spun-out from the company upon the closing of the Merger. Further, RENS has agreed that, upon the closing of the Merger, it will deliver its outstanding warrant to purchase 375,000 shares of common stock to the company for cancellation. In addition, Ren agreed to resign as MYOS' Global Chairman and as a member of MYOS' board of directors, which he did July 13.

07:59 EDT NOCCCD adds BIO-key 's PortalGuard as IAM solution - BIO-key International announced that the company's footprint in providing IAM for higher education continues to grow within the California Community College System with fifty colleges under support. The North Orange County Community College District chose the PortalGuard solution to improve their security posture and deliver a frictionless access experience for every end-user.

07:46 EDT Scholar Rock appoints Edward Myles as CFO - Scholar Rock (SRRK) announced the appointment of Edward Myles, as CFO and Head of Business Operations, responsible for finance, investor relations, corporate communications, IT and facilities. Mr. Myles has served on Scholar Rock's board, including as chair of the audit committee and a member of the compensation committee since November 2018. He is stepping down from the board in connection with his appointment to the executive leadership team. Ted Myles most recently served as CFO and COO of AMAG Pharmaceuticals (AMAG).

07:35 EDT Domino's Pizza CFO Jeffery Lawrence retiring - Domino's Pizza CFO and Executive Vice President Jeffrey Lawrence is retiring from Domino's after more than 20 years of service. Lawrence has agreed to continue serving as CFO until the company identifies his successor. Once a successor is named, he will step down from his role and will serve as an advisor to Domino's CEO Ritch Allison until the end of 2020.

07:33 EDT Abbott reports Q2 Worldwide Medical Devices sales down 21.2% on reported basis - Worldwide Medical Devices sales decreased 21.2% on a reported basis in the second quarter and decreased 19.9% on an organic basis. Sales growth was negatively impacted by reduced cardiovascular and neuromodulation procedure volumes due to COVID-19. Procedure volume trends improved significantly over the course of the second quarter as both demand for procedures and availability of healthcare resources began to return to more normalized levels.

07:32 EDT Kiniksa receives Orphan Drug designation for rilonacept for pericarditis - Kiniksa Pharmaceuticals (KNSA) announced that the U.S. Food and Drug Administration granted Orphan Drug designation for rilonacept for the treatment of pericarditis, which includes recurrent pericarditis. Rilonacept is a weekly, subcutaneously-injected, recombinant fusion protein that blocks interleukin-1 alpha and interleukin-1 beta signaling. Kiniksa recently reported positive data from RHAPSODY, a pivotal Phase 3 trial of rilonacept in recurrent pericarditis. RHAPSODY met its prespecified primary and all major secondary efficacy endpoints, showing that rilonacept improved clinically-meaningful outcomes associated with the unmet medical need in recurrent pericarditis. Rilonacept was discovered and developed by Regeneron Pharmaceuticals (REGN) and is approved by the FDA under the brand name ARCALYST for the treatment of for Cryopyrin-Associated Periodic Syndromes. Kiniksa licensed rilonacept from Regeneron in 2017 for evaluation in diseases believed to be mediated by both IL-1alpha and IL-1beta, including recurrent pericarditis. The FDA granted Breakthrough Therapy designation to rilonacept for recurrent pericarditis in 2019. Based on the Phase 3 RHAPSODY data, the Biologic License Application for CAPS will transfer to Kiniksa, and the company plans to submit a supplemental Biologic License Application in recurrent pericarditis to the FDA later this year. Upon receipt of FDA approval for rilonacept in recurrent pericarditis, Kiniksa would assume the sales and distribution of rilonacept for the approved indications in the United States and would evenly split profits on sales with Regeneron.

07:23 EDT Corvus Gold announces oxide gold discovery at Lynnda Strip target - Corvus Gold announces it has received positive drilling results from its new Lynnda Strip target located approximately 2.5 kilometres to the north-northeast of the Mother Lode deposit and about half way between Mother Lode and AngloGold Ashanti's Silicon project. The Lynnda Strip mineralization is a combination of structurally and stratigraphically controlled oxide gold below approximately 150 metres of cover. Drill hole CH20-11 returned an oxide zone totalling 197m @ 0.44 g/t Gold including 44.2m @ 0.90 g/t Gold & 20m @ 0.74 g/t Gold. Higher-grade intervals are associated with stockwork quartz veining hosted in volcanic rocks which is similar to the historic Bullfrog Mine and Corvus Gold's YellowJacket gold deposits. Corvus Gold will be conducting a follow-up drill program to test the upper part of the system, which Corvus Gold projects to be higher grade. The Lynnda Strip target has a distinctive geophysical signature as shown in data from Corvus Gold's new AMT survey. This same geophysical pattern occurs approximately 3.0 kilometres to the west of Lynnda Strip at Corvus Gold's Twisted Canyon target, which also has a coincident surface gold anomaly. Corvus Gold is working on a number of other targets generated by the Mother Lode Belt geophysical survey as well as follow-up work on drill results from Cat Hill and other targets tested in the North Bullfrog project area. In addition, Corvus Gold has developed two new targets, Hidden Valley and East Prospector, on its new Snake Claims east of AngloGold Ashanti's Silicon discovery. These two areas have attractive alteration systems. At Hidden Canyon, Corvus has found surface vein occurrences indicative of the upper levels of productive gold systems like those found elsewhere in the Bullfrog Mining District. Further follow-up work and drill targeting on these new Corvus Gold targets is ongoing.

07:20 EDT GasLog, GasLog Partners refinance 2021 debt maturities - GasLog (GLOG) and GasLog Partners (GLOP) announced the signing of three new loan agreements, The GasLog Ltd. $577M Facility, the GasLog Partners LP $260M Facility and the GasLog Partners LP $200M Facility, which substantially refinance all of the Group's debt maturities due in 2021, strengthen the balance sheet and create additional liquidity for the Group. The key highlights of the transactions are as follows: Refinances a total of approximately $1 billion of debt outstanding across 12 vessels; Delivery of approximately $30 million of incremental liquidity for the Group; Amortization profile of minimum 22-years and above with a 5-year tenor; Attractive weighted-average margin; Covenants in line with the Group's existing bank credit facilities and its NOK 2024 bond; Simplifies the Group's bank debt into GasLog Ltd. and GasLog Partners LP. facilities. The three new credit facilities are signed and expected to close by the end of July 2020. They fully refund the $266 million due on the Five Vessel Refinancing credit facility and refund the majority of the $724 million due on the Legacy Facility Refinancing. GasLog is currently in documentation to refinance the remaining balance of the Legacy Facility Refinancing, secured by the GasLog Chelsea, later in the third quarter.

07:19 EDT Morgan Stanley reports CET1 ratio at June 30 of 16.1% - At June 30, 2020 the Firm's Common Equity Tier 118 and Tier 118 risk-based capital ratios under the Advanced Approach were 16.1% and 18.1%, respectively and under the Standardized Approach the ratios were 16.5% and 18.6%, respectively. Supplementary leverage ratio and exposures in the current quarter include the Federal Reserve interim final rule relief in effect until March 31, 2021.

07:18 EDT Morgan Stanley reports Q2 ROE 15.7%, ROTCE 17.8% - The Firm's allowance for credit losses on loans held for investment increased by 40% to $866 million as of June 30, 2020 with a provision for credit losses of $246 million in the current quarter. Institutional Securities net revenues increased 56% reflecting outperformance across the businesses. Sales and Trading up 68% on strong client engagement as markets stabilized; Underwriting up 64% as clients accessed the open capital markets to strengthen their balance sheets. Wealth Management delivered a pre-tax income of $1.1 billion with a pre-tax margin of 24.4% despite a challenging market and rate environment. Bank lending increased 15% and brokerage sweep deposits were up $40 billion from a year ago. Investment Management reported both record long-term net flows of $15.4 billion and AUM of $665 billion driving revenue growth of 6%.

07:17 EDT Aprea Therapeutics expands clinical trial of eprenetapopt for TP53 Mutant AML - Aprea Therapeutics announced the expansion of patient enrollment in its Phase 1 clinical trial evaluating eprenetapopt in TP53 mutant AML. Following the completion of the safety lead-in portion of the clinical trial, the first expansion cohort will evaluate the combination of eprenetapopt with venetoclax and azacitidine in frontline TP53 mutant AML. The Company also plans to activate a cohort in the trial that will evaluate eprenetapopt with azacitidine in frontline TP53 mutant AML, expanding upon results for TP53 mutant AML patients recently presented from two independent Phase 1b/2 clinical trials. The lead-in portion of the Phase 1 AML Trial evaluated the tolerability of eprenetapopt with venetoclax, with or without azacitidine, and no dose-limiting toxicities were observed in patients receiving either regimen. The expansion part of the clinical trial will treat approximately 30 front-line TP53 mutant AML patients with the triplet therapy of eprenetapopt with venetoclax and azacitidine. The Company will also evaluate front-line treatment with the doublet therapy of eprenetapopt and azacitidine in approximately 30 additional TP53 mutant AML patients. Safety and efficacy will be evaluated in both patient cohorts.

07:14 EDT KVH Industries receives $10M order for TACNAV tactical navigation systems - KVH Industries announced that it has received a new order with a net value of more than $10M for its TACNAV tactical navigation systems for use by an international military customer. All hardware deliveries for this order are scheduled to take place in 2020. KVH's fiber optic gyro-based TACNAV systems are designed to provide unjammable inertial navigation data that fills in the gaps when GNSS is lost or unavailable, helping to keep soldiers and missions on track. The TACNAV solutions deliver critical, reliable performance in demanding environments for vehicles ranging from battle tanks and M-ATVs, to armored vehicles, reconnaissance, and combat support vehicles. TACNAV systems are currently in use by the U.S. Army and Marine Corps, as well as many allied customers including Australia, Botswana, Brazil, Canada, Egypt, France, Germany, Great Britain, Italy, Malaysia, New Zealand, Poland, Romania, Saudi Arabia, Singapore, South Korea, Spain, Sweden, Switzerland, Taiwan, and Turkey.

07:12 EDT Abiomed announces FDA approval of data streaming from Impella console - The FDA has approved one-way digital data streaming during patient support from Abiomed's Automated Impella Controller, or AIC, the external console used with Impella heart pumps. Abiomed said in a release, "The data streaming capability is facilitated through the Impella Connect interface, a HIPAA-compliant, cloud-based remote monitoring platform that is currently installed at more than 200 hospitals. The approval means console data could be streamed live via Impella Connect to a secure server where artificial intelligence could provide predictive clinical information to the patient's physician."

07:10 EDT Silence Therapeutics announces Mallinckrodt exercise of options - Silence Therapeutics (SLNCF) announces that Mallinckrodt (MNK) has exercised the option, under the collaboration agreement announced in July 2019, to obtain exclusive worldwide licenses for two additional complement-targeted RNAi assets from Silence. Silence will receive a $2M milestone payment upon initiation of work for each asset, the parties anticipate starting work on both programmes in due course. The collaboration between Silence and Mallinckrodt is aimed at the development and commercialisation of RNA therapeutics designed to inhibit or 'silence' the complement cascade, a group of proteins that are involved in the immune system and that play a role in the development of inflammation. These proteins are known to contribute to the pathogenesis of many diseases, including autoimmune diseases. Under the terms of the collaboration agreement, Silence will be responsible for preclinical activities and for executing the development programme of each asset until the end of Phase 1, after which Mallinckrodt will assume clinical development and responsibility for the global commercialisation of the assets. Mallinckrodt will fund Phase 1 clinical development including GMP manufacture. Silence will fund all other preclinical activities. Including the $2M milestone outlined above, Silence is eligible to receive up to $10M in research milestones for each asset, and up to $703M per asset in clinical, regulatory and commercial milestones. Silence will also receive tiered, low double-digit to high-teen royalties on net sales for each asset. In addition to the two new targets announced today, Mallinckrodt and Silence are already collaborating on the development of a RNAi therapeutic designed to target C3. IND enabling activities have been initiated for the C3 targeted programme.

07:09 EDT Procter & Gamble to make operations carbon neutral for the decade - Procter & Gamble announced a new commitment to have its global operations be carbon neutral for the decade through a series of interventions that protect, improve and restore nature. Procter & Gamble said in a release, "Recognizing the next decade represents a critical window for the world to accelerate progress on climate change, P&G will go beyond its existing Science Based Target of reducing greenhouse gas emissions by 50% by additionally advancing a portfolio of natural climate solutions. These efforts will deliver a carbon benefit that balances any remaining emissions over the next 10 years, allowing P&G operations to be carbon neutral for the decade. Based on current estimates, the Company will need to balance ~30 million metric tons of carbon from 2020 to 2030. P&G's priority continues to be reducing emissions. P&G has an existing goal of reducing greenhouse gas emissions by 50% and purchasing 100% renewable electricity by 2030 and is on track to deliver on its 2030 commitments. In addition, P&G will continue pursuing new wind, solar and geothermal projects to further accelerate the transition to renewables. These efforts are aligned with what climate science says is needed to help ensure the Company does its part to limit global temperature increase and will continue well beyond 2030. However, based on today's technologies, there are some emissions that cannot be eliminated by 2030. By investing in natural climate solutions, the Company will accelerate its impact over the next 10 years."

07:07 EDT Barrick Gold reports Q2 sales of 1.22M ounces of gold, 123M pounds of copper - Barrick Gold reported preliminary second quarter sales of 1.22 million ounces of gold and 123 million pounds of copper, as well as preliminary second quarter production of 1.15 million ounces of gold and 120 million pounds of copper. Group gold production for the first six months of 2020 was 2.4 million ounces, at the midpoint of the Company's 4.6 to 5.0 million ounce guided range for the year. The average market price for gold in the second quarter was $1,711 per ounce, while the average market price for copper in the second quarter was $2.43 per pound. Preliminary second quarter gold production was, as previously guided, lower than the first quarter of 2020. This was mainly due to the impact of Covid-19 at Veladero in Argentina where quarantine restrictions were lifted in April and movement and social distancing restrictions slowed the remobilization of employees and contractors back to site, a planned maintenance shutdown at Pueblo Viejo in the Dominican Republic and reduced production at Porgera in Papua New Guinea as the mine was placed on care and maintenance on April 24, 2020. Preliminary second quarter gold sales were in line with the previous quarter, and were higher than production in the second quarter following the start of exports of concentrate stockpiled in Tanzania. Second quarter gold cost of sales per ounce2 are expected to be 4-6% higher, total cash costs per ounce3 are expected to be 2-4% higher and gold all-in sustaining costs per ounce are expected to be 7-9% higher, respectively, than the first quarter of 2020. Preliminary second quarter copper production and sales were both higher than the previous quarter. Second quarter copper cost of sales per pound are expected to be 5-7% higher than the prior quarter. C1 cash costs per pound are expected to be in line and copper all-in sustaining costs per pound are expected to be 4-6% higher, respectively, than the first quarter of 2020.

07:04 EDT EU passenger car registrations down 22.3% in June - In June, registrations of new passenger cars in the EU1 totaled 949,722 units, a drop of 22.3% compared to the same month last year, when 1,222,942 cars were sold, the European Automobile Manufacturers Association reported. "However, this does mark a slight improvement over May 2020, which saw a drop of 52.3% across the European Union. Although dealerships opened for business again after lockdown measures were lifted, consumer demand did not fully recover last month," the group said. All EU markets continued to post significant declines in June, with France's 1.2% increase being the only exception to the rule, the ACEA added. Publicly traded automakers include Daimler AG (DDAIF), Fiat Chrysler (FCAU), Ford (F), General Motors (GM), Honda (HMC), Nissan (NSANY), Tesla (TSLA), Toyota (TM) and Volkswagen (VWAGY).

07:02 EDT Bank of America CFO: We are well prepared for the current environment - CFO Paul Donofrio: "We strengthened an already strong balance sheet by increasing capital and liquidity and growing deposits. While net charge-offs remained relatively low by historical standards, we added another $4 billion to credit reserves to reflect the current economic outlook. We ended the quarter with record deposits of $1.7 trillion, $242 billion in common equity, and $21 billion in credit reserves that we believe will allow us to continue to be a source of strength for our clients and communities. Our continued focus on Responsible Growth means we are well prepared for the current environment."

06:58 EDT Standex acquires Renco Electronics for ~$28M in cash - Standex International announced that it has acquired privately-held, Florida-based Renco Electronics for approximately $28 million in cash with an additional three-year earnout payment based upon achieving certain financial targets. Standex said in a release, "The transaction is being financed from Standex's existing cash balance. The company expects the acquisition to be accretive to its earnings in its first year of ownership as well as additive to consolidated free cash flow. The company has approximately 120 employees and is headquartered in Rockledge, Florida with manufacturing facilities in Rockledge and Asia."

06:55 EDT Bank of America reports Q2 net interest income down 11% to $10.8B - Driven by lower interest rates, partially offset by loan and deposit growth. Noninterest income rose 5% to $11.5B, led by strong capital markets results.

06:52 EDT Bank of America reports Q2 book value up 6% to $27.96 - Tangible book value per common share rose 5% to $19.90.

06:49 EDT Merck: FDA grants priority review to new drug application for vericigua - Merck (MRK) announced that the U.S. FDA has accepted for priority review the New Drug Application for vericiguat, an orally administered soluble guanylate cyclase stimulator, to reduce the risk of cardiovascular death and heart failure hospitalization following a worsening heart failure event in patients with symptomatic chronic heart failure with reduced ejection fraction, in combination with other heart failure therapies. The FDA has set a Prescription Drug User Fee Act, or target action date, of Jan. 20, 2021. Vericiguat is being jointly developed with Bayer AG (BAYRY).

06:37 EDT ChromaDex's Niagen shows social deficit reduction in mouse model of autism - ChromaDex announced the results of a new preclinical study published in Nature Scientific Reports investigating the role of Niagen in addressing social deficits in Autism Spectrum Disorder. This new study joins a body of preclinical data demonstrating that boosting NAD+ - nicotinamide adenine dinucleotide - levels may have a positive effect on cognitive health. The study was the first to evaluate Niagen in an Autism model. Daily Niagen supplementation was found to correct social deficits such as fearful and anxiety-like behavior in the male CD157 mice. Following supplementation, these mice were better able to recognize and display interest in other mice. More research is required to translate the health potential of Niagen from mice to humans. Over 40 human clinical trials have been or are being conducted on Niagen across a multitude of organ systems and chronic conditions. ChromaDex has demonstrated the safety and efficacy of Niagen in ten published human trials and over 20 ongoing studies and has achieved government regulatory acceptance in the U.S., Canada, the E.U., and Australia.

06:34 EDT Viavi enters supply agreement, patent license with VeEX, terms not disclosed - Viavi Solutions announced that they have agreed to a patent license related to cable leakage and pressure testing as well as a supply agreement where VeEX will be able to distribute the VIAVI Seeker HL Source Transmitter and pair it with a VeEX receiver - such as the VeEX CX310 - for use in detecting cable signal leakage. Viavi said in a release, "The patented VIAVI technology includes the Seeker HL Source Transmitter to provide a simple, efficient solution to help eliminate intermittent issues related to unwanted signal leakage and ingress in a home coaxial network. The Seeker HL Source Transmitter injects two high output test carriers to the home network in the place of cable signals, and "pressurizes" the home network, revealing any damage or craftsmanship issues that may lead to service interruption from LTE carrier or other ambient RF signal ingress. A leaking signal can be detected by a technician using a properly optioned VIAVI ONX or DSP meter, or the VeEX CX310 receiver. The technician can then save the time otherwise needed to find and fix a faulty component or rewire the entire home. The terms and conditions of the supply agreement and patent license are confidential and are not being disclosed."

06:18 EDT Linde signs MoU with China Power subsidiary to develop green hydrogen - Linde announced today that it has signed a memorandum of understanding, or MoU, with Beijing Green Hydrogen, a subsidiary of China Power, to jointly promote the application and development of green hydrogen in China. Under the terms of the MoU both companies will collaborate on a variety of green hydrogen initiatives, including hydrogen technology research and development and the implementation of green hydrogen mobility solutions during China's hosting of the 2022 Winter Olympics.

06:06 EDT KBR awarded contract by Kutch Specialities - KBR has been awarded a contract for its proprietary Plinke Adiabatic Nitrobenzene solutions by Kutch Specialities. KBR said in a release, "Under the terms of the contract, KBR will provide basic and detailed engineering design, equipment, and related advisory services to Kutch Specialities Pvt Ltd for its grassroots nitrobenzene project in India. KBR's proven process, patented equipment design, and material selection ensure plant availability and reliability to produce a high purity nitrobenzene with a focus on high energy efficiency and environmental sustainability. Amongst other products, Nitrobenzene is used for the production of polyurethane foams, rubber chemicals, dyes and pharmaceuticals."

06:05 EDT Farmmi receives new customer order for export to U.S. - Farmmi announced its subsidiary Zhejiang Forest Food, has received a new customer order for its dried whole mushrooms and dried mushroom slices. Farmmi said in a release, "The customer, an investment trading company supplying major global hotel and supermarket chains, including the STANFORD hotel chain and the H-MART supermarket chain, will export the mushrooms to the U.S."

06:03 EDT Check Point Research, Zoom collaborate to fix 'Vanity URL' issue - Check Point Research, the Threat Intelligence arm of Check Point Software Technologies (CHKP), recently helped to mitigate risk associated with a potential security issue in Zoom's (ZM) customizable 'Vanity URLs' feature that could have allowed hackers to send legitimate-looking Zoom business meeting invitations that appear as associated with a particular Zoom user with the aim of inserting malware and surreptitiously stealing data or credentials from that user. Previously, Check Point Research worked with Zoom this past January to fix a different potential vulnerability that could have allowed hackers to join a meeting uninvited. Zoom usage has exploded during the global Covid-19 lockdowns, from 10M daily meeting participants in December 2019 to over 300M in April 2020. Cybercriminals are using this popularity as phishing lure for Zoom and other video communication platform users. According to Check Point, Zoom-related domain registrations and fake Zoom installation programs, in particular, have been the subject of a major increase.Check Point Research and Zoom worked together to resolve these issues. Zoom has addressed the issue and put additional safeguards in place for the protection of users.

05:29 EDT Liberty Formula One, Zoom Video announce first virtual paddock club partnership - Formula 1 (FWONA) and Zoom Video (ZM) announced a new digital partnership to deliver the first ever virtual Paddock Club experience, ahead of the FORMULA 1 ARAMCO MAGYAR NAGYDIJ 2020 Budapest. The companies said in a release, "The video-first unified communications platform, which set a new business record in April 2020 by reaching over 300 million daily meeting participants, is working with F1 to provide new business opportunities through unique, live-sport experiences.Due to the ongoing pandemic, the first eight races are without the traditional in-person hospitality offerings. Hospitality is a key component of the F1 experience, so the companies partnered to create a bespoke virtual hospitality experience for guests. Across the past race weekend, guests joined the Virtual Paddock Club, through Zoom, and were treated to a range of experiences, including live updates and insight from legends of the paddock. Additional experiences will also be created, in-line with the FIA's regulations, at future races. Zoom will provide an exclusive experience throughout the eight-race European season, and in addition, F1 will look to work with Zoom to expand the Virtual Paddock Club offering to its Global Partners and F1 Teams."

05:19 EDT Motorola Solutions announces body-worn camera order from Romanian Police - Motorola Solutions said in a release, "Motorola Solutions announced that the General Inspectorate for the Romanian Police, the national police force and main civil law enforcement agency in Romania, has signed for an integrated body-worn camera solution which consists of 12,000 VB400 body-worn cameras including back-end VideoManager software, to improve the safety of both the police and the public, and enhance the accountability of their front-line police forces."